Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $356M (100.0% shares, 0.0% debt)

Holdings (44)

XBI SPDR SER TR 11.1%
Value $39.66M Shares 500,000 Est. Cost Unrealized
APLS APELLIS PHARMACEUTICALS INC 5.3%
Value $18.78M Shares 275,000 Est. Cost $51.44 Unrealized +15.0%
RLMD RELMADA THERAPEUTICS INC 5.2%
Value $18.51M Shares 500,000 Est. Cost $25.40 Unrealized +9.1%
REATA PHARMACEUTICALS INC 5.1%
Value $18.22M Shares 725,000 Est. Cost $25.13 Unrealized
RLMD RELMADA THERAPEUTICS INC 4.4%
Value $15.73M Shares 425,000 Est. Cost $25.40 Unrealized +9.1%
AMLX AMYLYX PHARMACEUTICALS INC 4.3%
Value $15.48M Shares 550,000 Est. Cost $24.95 Unrealized 0.0%
DICE THERAPEUTICS INC 4.0%
Value $14.2M Shares 700,000 Est. Cost $15.53 Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 4.0%
Value $14.07M Shares 500,000 Est. Cost $24.95 Unrealized 0.0%
AXSM AXSOME THERAPEUTICS INC 3.8%
Value $13.39M Shares 300,000 Est. Cost $36.01 Unrealized +38.7%
MIRATI THERAPEUTICS INC 3.4%
Value $12.22M Shares 175,000 Est. Cost $71.70 Unrealized
SRPT SAREPTA THERAPEUTICS INC 3.4%
Value $12.16M Shares 110,000 Est. Cost $78.15 Unrealized +29.0%
CTI BIOPHARMA CORP 3.3%
Value $11.64M Shares 2,000,000 Est. Cost $4.68 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 3.1%
Value $10.97M Shares 535,000 Est. Cost $17.40 Unrealized +3.3%
REVANCE THERAPEUTICS INC 3.0%
Value $10.53M Shares 390,000 Est. Cost $27.00 Unrealized
ASND ASCENDIS PHARMA A/S 2.8%
Value $9.81M Shares 95,000 Est. Cost $125.70 Unrealized
COGT COGENT BIOSCIENCES INC 2.5%
Value $8.952M Shares 600,000 Est. Cost $10.34 Unrealized +32.5%
PCVX VAXCYTE INC 2.4%
Value $8.64M Shares 360,000 Est. Cost $22.18 Unrealized +14.3%
IVERIC BIO INC 2.3%
Value $8.319M Shares 463,700 Est. Cost $7.65 Unrealized
SEAGEN INC 1.9%
Value $6.842M Shares 50,000 Est. Cost $176.94 Unrealized
KARUNA THERAPEUTICS INC 1.9%
Value $6.748M Shares 30,000 Est. Cost $126.78 Unrealized
AXSM AXSOME THERAPEUTICS INC 1.9%
Value $6.693M Shares 150,000 Est. Cost $36.01 Unrealized +38.7%
BCRX BIOCRYST PHARMACEUTICALS INC 1.9%
Value $6.615M Shares 525,000 Est. Cost $14.83 Unrealized -13.2%
ALT ALTIMMUNE INC 1.6%
Value $5.555M Shares 435,000 Est. Cost $14.76 Unrealized 0.0%
TRICIDA INC 1.5%
Value $5.24M Shares 500,000 Est. Cost $10.48 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.5%
Value $5.22M Shares 500,000 Est. Cost $11.01 Unrealized +1.2%
REATA PHARMACEUTICALS INC 1.4%
Value $5.026M Shares 200,000 Est. Cost $25.13 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.3%
Value $4.806M Shares 200,000 Est. Cost $18.21 Unrealized +23.2%
HORIZON THERAPEUTICS PUB L 1.3%
Value $4.642M Shares 75,000 Est. Cost $79.76 Unrealized
KEZAR LIFE SCIENCES INC 1.3%
Value $4.52M Shares 525,000 Est. Cost $14.73 Unrealized
ASTRIA THERAPEUTICS INC 1.3%
Value $4.52M Shares 500,000 Est. Cost $9.04 Unrealized
BLUEPRINT MEDICINES CORP 1.2%
Value $4.283M Shares 65,000 Est. Cost $65.89 Unrealized
WHWK AADI BIOSCIENCE INC 0.8%
Value $2.826M Shares 200,000 Est. Cost $22.12 Unrealized -40.6%
INTRA-CELLULAR THERAPIES INC 0.8%
Value $2.792M Shares 60,000 Est. Cost $46.53 Unrealized
AEROVATE THERAPEUTICS INC 0.7%
Value $2.487M Shares 150,000 Est. Cost $16.58 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.7%
Value $2.328M Shares 300,000 Est. Cost $6.29 Unrealized +12.0%
RAPT THERAPEUTICS INC 0.6%
Value $2.165M Shares 90,000 Est. Cost $33.20 Unrealized
TRICIDA INC 0.6%
Value $2.096M Shares 200,000 Est. Cost $10.48 Unrealized
TARS TARSUS PHARMACEUTICALS INC 0.6%
Value $2.054M Shares 120,000 Est. Cost $31.23 Unrealized -49.2%
DSGN DESIGN THERAPEUTICS INC 0.5%
Value $1.672M Shares 100,000 Est. Cost $15.73 Unrealized +26.5%
MDGL MADRIGAL PHARMACEUTICALS INC 0.5%
Value $1.625M Shares 25,000 Est. Cost $69.48 Unrealized 0.0%
RYTM RHYTHM PHARMACEUTICALS INC 0.4%
Value $1.593M Shares 65,000 Est. Cost $18.60 Unrealized 0.0%
IVERIC BIO INC 0.3%
Value $1.1M Shares 61,300 Est. Cost $7.65 Unrealized
BIIB BIOGEN INC 0.3%
Value $1.001M Shares 3,750 Est. Cost $212.38 Unrealized 0.0%
AEGLEA BIOTHERAPEUTICS INC 0.1%
Value $526K Shares 1,000,000 Est. Cost $1.74 Unrealized